(S)-Methyl 2-(3-Amino-4-((S)-2-amino-5-guanidinopentanamido)benzamido)-3-(4-hydroxyphenyl)-propanoate

ID: ALA3416729

Chembl Id: CHEMBL3416729

PubChem CID: 118734296

Max Phase: Preclinical

Molecular Formula: C23H31N7O5

Molecular Weight: 485.55

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  COC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)c1ccc(NC(=O)[C@@H](N)CCCNC(=N)N)c(N)c1

Standard InChI:  InChI=1S/C23H31N7O5/c1-35-22(34)19(11-13-4-7-15(31)8-5-13)30-20(32)14-6-9-18(17(25)12-14)29-21(33)16(24)3-2-10-28-23(26)27/h4-9,12,16,19,31H,2-3,10-11,24-25H2,1H3,(H,29,33)(H,30,32)(H4,26,27,28)/t16-,19-/m0/s1

Standard InChI Key:  RQXULMRCYOSEPW-LPHOPBHVSA-N

Alternative Forms

  1. Parent:

    ALA3416729

    ---

Associated Targets(Human)

ERAP1 Tchem Endoplasmic reticulum aminopeptidase 1 (581 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ERAP2 Tchem Endoplasmic reticulum aminopeptidase 2 (387 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
LNPEP Tchem Cystinyl aminopeptidase (313 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 485.55Molecular Weight (Monoisotopic): 485.2387AlogP: 0.02#Rotatable Bonds: 11
Polar Surface Area: 218.67Molecular Species: BASEHBA: 8HBD: 8
#RO5 Violations: 1HBA (Lipinski): 12HBD (Lipinski): 11#RO5 Violations (Lipinski): 2
CX Acidic pKa: 9.50CX Basic pKa: 11.98CX LogP: -0.67CX LogD: -3.02
Aromatic Rings: 2Heavy Atoms: 35QED Weighted: 0.07Np Likeness Score: -0.07

References

1. Papakyriakou A, Zervoudi E, Tsoukalidou S, Mauvais FX, Sfyroera G, Mastellos DC, van Endert P, Theodorakis EA, Vourloumis D, Stratikos E..  (2015)  3,4-diaminobenzoic acid derivatives as inhibitors of the oxytocinase subfamily of M1 aminopeptidases with immune-regulating properties.,  58  (3): [PMID:25635706] [10.1021/jm501867s]

Source